D. E. Shaw & Co., Inc. Essa Pharma Inc. Call Options Transaction History
D. E. Shaw & Co., Inc.
- $98.6 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EPIX
# of Institutions
34Shares Held
35.2MCall Options Held
37.7KPut Options Held
3.8K-
Bvf Inc San Francisco, CA8.75MShares$15 Million1.41% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.89MShares$13.5 Million0.69% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.21MShares$7.2 Million2.24% of portfolio
-
Morgan Stanley New York, NY4.18MShares$7.14 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.97MShares$5.07 Million0.8% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $75.4M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...